AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BioGaia

Earnings Release Oct 13, 2021

3013_rns_2021-10-13_c0b2a500-236c-4e88-8d9d-c09845025470.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

BioGaia's profit for third quarter to exceed market expectations

(Figures in brackets refer to the year-earlier period)

In the latter part of the third quarter of 2021, BioGaia was requested by certain customers at risk of running out of stock to bring orders forward, which has had a positive impact on sales for the quarter.

Sales for the third quarter are preliminarily estimated at SEK 174 million (132), up 32%. Operating profit for the third quarter is preliminarily estimated at SEK 67 million (27), up 148%. Full-year sales are largely expected to be in line with expectations.

BioGaia will publish the interim report for the third quarter on Thursday, 21 October 2021 at 8:00 a.m., followed by a teleconference at 9:30 a.m.

This is information that BioGaia AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the CEO, at 9:00 p.m. CEST on 13 October 2021.

For more information, please contact: Isabelle Ducellier, CEO: +46 8 555 293 00

Talk to a Data Expert

Have a question? We'll get back to you promptly.